弹性可以确定神经肌肉阻塞对急性呼吸困扰综合征死亡率的影响
Ann A Zalucky1,2, Jose Dianti3, Lucile P A Neyton1
1University of California San Francisco, San Francisco, California, United States.
American journal of respiratory and critical care medicine
|February 25, 2025
概括
神经肌肉阻塞 (NMB) 显示,急性呼吸困扰综合征 (ARDS) 患者的死亡率增加,呼吸系统弹性 (Ers) 高. 高Er可能表明特定的ARDS表型值得进一步研究.
科学领域:
- 关键护理医学 关键护理医学
- 肺部医学 肺部医学
- 呼吸系统生理学 呼吸系统生理学
背景情况:
- 急性呼吸困难综合征 (ARDS) 的特征是肺体积减少和呼吸系统弹性 (Ers) 增加.
- 在ARDS患者中,较高的Ers与肺疏远压力的风险增加有关.
- 神经肌肉阻塞 (NMB) 被认为是ARDS患者,但它的益处可能会根据生理特征而有所不同.
研究的目的:
- 调查ARDS早期NMB的死亡益处是否与基线生理和生物标志物有所不同.
- 具体来说,评估呼吸系统弹性 (Ers) 在缓解NMB对90天死亡率的影响中的作用.
主要方法:
- 对ROSE (系统性早期神经肌肉阻塞的重新评估) 试验数据的二次分析.
- 贝叶斯逻辑回归建模,以评估NMB和基线生物标志物 (Ers,呼吸器比率,ARDS等离子体生物标志物) 在死亡率上的相互作用.
- 对相互作用的后期概率和可信度间隔的评估.
主要成果:
- 从NMB获得死亡益处的概率显著增加,基线Ers较高 (后来的相互作用概率:92%).
- 在Ers≥2cmH2O/mL/kg的患者中,NMB的益处概率为96% (绝对风险降低的中位数为9%).
- 对于NMB的效果与呼吸器比率或ARDS血生物标志物 (例如RAGE,TNFR-1,IL-6,IL-8) 并没有显著变化.
结论:
- 在ARDS中早期NMB的死亡益处取决于基线呼吸系统弹性 (Ers).
- 高 Ers可能会识别出对NMB有好反应的ARDS生理表型.
- 需要进一步的前性研究来证实NMB在这个特定的患者亚组中的益处.
相关概念视频
Skeletal Muscle Relaxants: Adverse Effects
328
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
328
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
384
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
384
Skeletal Muscle Relaxants: Therapeutic Uses
458
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
458
Depolarizing Blockers: Mechanism of Action
1.1K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.1K
Depolarizing Blockers: Pharmocokinetics
300
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
300
Acute Respiratory Failure-IV
116
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
116


